Arrowstreet Capital Limited Partnership Acquires 11,126 Shares of The Cooper Companies, Inc. $COO

Arrowstreet Capital Limited Partnership lifted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 2.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 521,707 shares of the medical device company’s stock after purchasing an additional 11,126 shares during the period. Arrowstreet Capital Limited Partnership owned 0.26% of Cooper Companies worth $37,125,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the business. Zions Bancorporation National Association UT bought a new position in Cooper Companies during the first quarter valued at about $33,000. J.Safra Asset Management Corp boosted its stake in shares of Cooper Companies by 204.8% during the 2nd quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock worth $36,000 after acquiring an additional 340 shares in the last quarter. GKV Capital Management Co. Inc. acquired a new position in shares of Cooper Companies during the 1st quarter valued at about $40,000. Assetmark Inc. increased its holdings in shares of Cooper Companies by 357.8% during the 2nd quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock valued at $44,000 after acquiring an additional 483 shares during the last quarter. Finally, Allworth Financial LP raised its stake in shares of Cooper Companies by 36.6% in the 2nd quarter. Allworth Financial LP now owns 959 shares of the medical device company’s stock valued at $68,000 after acquiring an additional 257 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Trading Up 5.7%

Cooper Companies stock opened at $81.40 on Friday. The business has a 50 day moving average price of $72.29 and a two-hundred day moving average price of $71.74. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. The stock has a market cap of $16.18 billion, a price-to-earnings ratio of 43.30, a price-to-earnings-growth ratio of 1.89 and a beta of 1.05. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $101.53.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a return on equity of 10.01% and a net margin of 9.16%.Cooper Companies’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. As a group, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies announced that its Board of Directors has authorized a stock repurchase plan on Wednesday, September 17th that allows the company to buyback $2.00 billion in outstanding shares. This buyback authorization allows the medical device company to repurchase up to 15.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its shares are undervalued.

Insiders Place Their Bets

In other Cooper Companies news, Director Lawrence Erik Kurzius purchased 2,000 shares of the stock in a transaction on Monday, September 29th. The shares were purchased at an average price of $68.39 per share, with a total value of $136,780.00. Following the acquisition, the director directly owned 5,777 shares of the company’s stock, valued at $395,089.03. This represents a 52.95% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 1.98% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have commented on COO shares. Wells Fargo & Company increased their price target on Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a report on Friday. Mizuho set a $100.00 price objective on shares of Cooper Companies and gave the stock an “outperform” rating in a report on Friday. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research note on Friday. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cooper Companies in a report on Monday. Finally, Stifel Nicolaus set a $95.00 price target on shares of Cooper Companies and gave the company a “buy” rating in a report on Friday. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $90.31.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.